NIH HEAL Initiative Workshop on Myofascial Pain
Date: September 16, 2020 - 08:45 a.m. ET to September 17, 2020 3:30 p.m. ET
Zoom and NIH Videocast
Workshop Summary
An executive summary for the NIH HEAL Initiative Workshop on Myofascial Pain is available: Quantitative Evaluation of Myofascial Tissues: Potential Impact for Musculoskeletal Pain Research Executive Summary [55KB PDF].
A full summary for the NIH Health Initiative Workshop on Myofascial Pain is also available: Quantitative Evaluation of Myofascial Tissues: Potential Impact for Musculoskeletal Pain Research Full Summary [1.81 MB PDF].
Event Description
Please join us for an NIH Helping to End Addiction Long-termSM (HEAL) Initiative Workshop on Myofascial Pain, “Quantitative Evaluation of Myofascial Tissues: Potential Impact for Musculoskeletal Pain Research.” This free two-day virtual workshop is jointly organized by the National Center for Complementary and Integrative Health and the National Institute of Biomedical Imaging and Bioengineering.
Experts in the field will present in-depth analyses of the state of science of myofascial pain, current usage of technologies (e.g., methodologies) and their limitations, current technologies to be adapted for myofascial pain biomarker imaging or recording, and emerging technologies and methodologies.
If you have questions, please email Myofascial_Pain_HEAL@mail.nih.gov.
NIH partners for this event include the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research, the National Institute of Dental and Craniofacial Research, and the National Institute of Neurological Disorders and Stroke.
Funding Opportunities
- HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) RFA-AT-22-003
- Frequently Asked Questions: HEAL Initiative—Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required); RFA-AT-22-003
- Coming Soon—A Funding Opportunity on Biomarkers for Myofascial Pain—Learn more about the Notice of Intent to Publish (NOITP) a new funding opportunity for myofasical reserach in Dr. Helene M. Langevin's Director’s Message. (August 19. 2021)